BHSRX
Price
$60.25
Change
+$0.19 (+0.32%)
Updated
Oct 8 closing price
Net Assets
6.32B
JNGLX
Price
$74.56
Change
+$0.48 (+0.65%)
Updated
Oct 8 closing price
Net Assets
4.49B
Interact to see
Advertisement

BHSRX vs JNGLX

Header iconBHSRX vs JNGLX Comparison
Open Charts BHSRX vs JNGLXBanner chart's image
BlackRock Health Sciences Opps R
Price$60.25
Change+$0.19 (+0.32%)
VolumeN/A
Net Assets6.32B
Janus Henderson Global Life Sciences D
Price$74.56
Change+$0.48 (+0.65%)
VolumeN/A
Net Assets4.49B
BHSRX vs JNGLX Comparison Chart in %
View a ticker or compare two or three
VS
BHSRX vs. JNGLX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHSRX is a Buy and JNGLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BHSRX has more cash in the bank: 6.32B vs. JNGLX (4.49B). JNGLX pays higher dividends than BHSRX: JNGLX (0.33) vs BHSRX (0.02). BHSRX was incepted earlier than JNGLX: BHSRX (14 years) vs JNGLX (27 years). BHSRX (1.46) is less costly to investors than JNGLX (0.80). BHSRX is a more actively managed with annual turnover of: 43.00 vs. JNGLX (35.00). BHSRX has a lower initial minimum investment than JNGLX: BHSRX (100) vs JNGLX (2500). JNGLX annual gain was more profitable for investors over the last year : -6.32 vs. BHSRX (-12.18). JNGLX return over 5 years is better than : 7.83 vs. BHSRX (-16.47).
BHSRXJNGLXBHSRX / JNGLX
Total Expense Ratio1.460.80183%
Annual Report Gross Expense Ratio1.460.80183%
Fund Existence14 years27 years-
Gain YTD-0.2499.118-3%
Front LoadN/AN/A-
Min. Initial Investment10025004%
Min. Initial Investment IRAN/AN/A-
Net Assets6.32B4.49B141%
Annual Yield % from dividends0.020.336%
Returns for 1 year-12.18-6.32193%
Returns for 3 years4.2024.1817%
Returns for 5 years-16.477.83-210%
Returns for 10 years18.8340.2447%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CHCCX4.20N/A
N/A
AB Discovery Growth C
TOLCX16.66N/A
N/A
DWS RREEF Global Infrastructure C
FIDZX38.34N/A
N/A
Fidelity Advisor Intl Cap App Z
SEKRX22.88N/A
N/A
DWS Emerging Markets Equity R6
PISJX16.05N/A
N/A
Columbia Pyrford International Stock R